• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of straninfSexually Transmitted InfectionsCurrent TOCInstructions for authors
Sex Transm Infect. Feb 2005; 81(1): 79–84.
PMCID: PMC1763723

Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain

Abstract

Objectives: To estimate the prevalence and risk factors of high risk human papillomavirus (HPV) infection in migrant female sex workers (FSW) according to age and geographical origin.

Methods: Cross sectional study of migrant FSW attending a sexually transmitted infection (STI) clinic in Madrid during 2002. Information on sociodemographic characteristics, reproductive and sexual health, smoking, time in commercial sex work, history of STIs, HIV, hepatitis B, hepatitis C, syphilis, and genitourinary infections was collected. High risk HPV Infection was determined through the Digene HPV Test, Hybrid Capture II. Data were analysed through multiple logistic regression.

Results: 734 women were studied. Overall HPV prevalence was 39%; 61% in eastern Europeans, 42% in Ecuadorians, 39% in Colombians, 29% in sub-Saharan Africans, and 24% in Caribbeans (p = 0.057). HPV prevalence showed a decreasing trend by age; 49% under 20 years, 35% in 21–25 years,14% over 36 years% (p<0.005). In multivariate analyses, area of origin (p = 0.07), hormonal contraception in women not using condoms (OR 19.45 95% CI: 2.45 to 154.27), smoking, age, and an interaction between these last two variables (p = 0.039) had statistically significant associations with HPV prevalence. STI prevalence was 11% and was not related to age or geographical origin.

Conclusions: High risk HPV prevalence in migrant FSW is elevated and related to age, area of origin, and use of oral contraceptives in women not using condoms. These data support the role of acquired immunity in the epidemiology of HPV infection and identifies migrant FSW as a priority group for sexual health promotion.

Full Text

The Full Text of this article is available as a PDF (79K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ferenczy Alex, Franco Eduardo. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002 Jan;3(1):11–16. [PubMed]
  • Muñoz Nubia, Bosch F Xavier, de Sanjosé Silvia, Herrero Rolando, Castellsagué Xavier, Shah Keerti V, Snijders Peter J F, Meijer Chris J L M. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518–527. [PubMed]
  • Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst. 1999 Mar 17;91(6):506–511. [PubMed]
  • Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001 Dec 26;286(24):3106–3114. [PubMed]
  • Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998 Feb 12;338(7):423–428. [PubMed]
  • Touzé A, de Sanjosé S, Coursaget P, Almirall MR, Palacio V, Meijer CJ, Kornegay J, Bosch FX. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol. 2001 Dec;39(12):4344–4348. [PMC free article] [PubMed]
  • Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Bodén E, Rylander E, Wadell G. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis. 1995 Mar-Apr;22(2):119–127. [PubMed]
  • Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001 Jun 20;285(23):2995–3002. [PubMed]
  • Baay MF, Tjalma WA, Weyler J, Goovaerts G, Buytaert P, Van Marck EA, Lardon F, Vermorken JB. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer. Eur J Gynaecol Oncol. 2001;22(3):204–208. [PubMed]
  • Winer Rachel L, Lee Shu-Kuang, Hughes James P, Adam Diane E, Kiviat Nancy B, Koutsky Laura A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003 Feb 1;157(3):218–226. [PubMed]
  • Rezza G, Giuliani M, Serraino D, Branca M, Benedetto A, Garbuglia A, Ippolito G, Franceschi S. Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group. Epidemiol Infect. 1998 Aug;121(1):173–177. [PMC free article] [PubMed]
  • de Sanjosé S, Valls I, Paz Cañadas M, Lloveras B, Quintana MJ, Shah KV, Bosch FX. Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas. Med Clin (Barc) 2000 Jun 17;115(3):81–84. [PubMed]
  • Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000 Sep;27(8):438–445. [PubMed]
  • Juárez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zampilpa-Mejía LG, García-Cisneros S, Hernández-Avila M. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis. 2001 Mar;28(3):125–130. [PubMed]
  • Ishi K, Suzuki F, Saito A, Kubota T. Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan. J Obstet Gynaecol Res. 2000 Aug;26(4):253–257. [PubMed]
  • Chatterjee R, Mukhopadhyay D, Murmu N, Jana S. Prevalence of human papillomavirus infection among prostitutes in Calcutta. J Environ Pathol Toxicol Oncol. 2001;20(2):113–117. [PubMed]
  • Castilla Jesús, Sobrino Paz, del Amo Julia. HIV infection among people of foreign origin voluntarily tested in Spain. A comparison with national subjects. Sex Transm Infect. 2002 Aug;78(4):250–254. [PMC free article] [PubMed]
  • de Villiers EM, Wagner D, Schneider A, Wesch H, Miklaw H, Wahrendorf J, Papendick U, zur Hausen H. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet. 1987 Sep 26;2(8561):703–706. [PubMed]
  • Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996 Jul-Aug;23(4):333–341. [PubMed]
  • Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001 Jun 9;357(9271):1831–1836. [PubMed]
  • Molano Monica, Van den Brule Adriaan, Plummer Martyn, Weiderpass Elisabete, Posso Hector, Arslan Annie, Meijer Chris J L M, Muñoz Nubia, Franceschi Silvia. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003 Sep 1;158(5):486–494. [PubMed]
  • Moreno Victor, Bosch F Xavier, Muñoz Nubia, Meijer Chris J L M, Shah Keerti V, Walboomers Jan M M, Herrero Rolando, Franceschi Silvia. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002 Mar 30;359(9312):1085–1092. [PubMed]
  • Madeleine MM, Daling JR, Schwartz SM, Shera K, McKnight B, Carter JJ, Wipf GC, Critchlow CW, McDougall JK, Porter P, et al. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):171–177. [PubMed]
  • Green J, Berrington de Gonzalez A, Smith JS, Franceschi S, Appleby P, Plummer M, Beral V. Human papillomavirus infection and use of oral contraceptives. Br J Cancer. 2003 Jun 2;88(11):1713–1720. [PMC free article] [PubMed]
  • de Villiers Ethel-Michele. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer. 2003 Mar 1;103(6):705–708. [PubMed]
  • Smith Jennifer S, Green Jane, Berrington de Gonzalez Amy, Appleby Paul, Peto Julian, Plummer Martyn, Franceschi Silvia, Beral Valerie. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003 Apr 5;361(9364):1159–1167. [PubMed]
  • Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994 Feb;169(2):235–240. [PubMed]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...